
|Videos|October 8, 2021
MOSES 2.0 upgrade for HoLEP demonstrates cost savings in BPH
Author(s)Urology Times staff
“Even factoring in the increased number of emergency room visits, there was still an overall cost savings of $747 in favor of the Moses HoLEP. So, that was surprising to see,” says Matthew S. Lee, MD.
Advertisement
In this video Matthew S. Lee, MD,discusses the background and findings of the Urology Practice study, “A cost comparison of holmium laser enucleation of the prostate with and without Moses.” Lee is an endourology fellow at Northwestern University, Evanston, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5


















